Table 1.

Study cohort, n = 137.

Age (years)	59.8 +/− 9.6
Females	38 (27.7%)
BMI kg/cm2	26.8 +/− 4.2
CVRF
Smokers (active)	14 (10.2%)
Arterial hypertension	50 (36.9%)
Dyslipidemia	56 (40.4%)
Diabetes	8 (5.8%)
Atrial fibrillation type
Paroxysmal Persistent	91 (66.4%) 46 (33.6%)
Medication
Vit-K inhibitors NOAC No anticoagulants (e.g., ASA)	9 (6.5%) 87 (63.6%) 41 (29.9%)

Abbreviations: BMI, body mass index; CVRF, cardiovascular risk factors; NOAK, novel oral anticoagulants (rivaroxaban, dabigatran, apixaban); ASA, acetylsalicylic acid.